🇺🇸 2016-2017 Quadrivalent Inactivated Influenza Vaccine in United States

2016-2017 Quadrivalent Inactivated Influenza Vaccine (2016-2017 Quadrivalent Inactivated Influenza Vaccine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

2016-2017 Quadrivalent Inactivated Influenza Vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is 2016-2017 Quadrivalent Inactivated Influenza Vaccine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for 2016-2017 Quadrivalent Inactivated Influenza Vaccine in United States?

Duke University is the originator. The local marketing authorisation holder may differ — check the official source linked above.